Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study of Cenobamate for Children with Partial-Onset Seizures
HungaryLong-Term Study on Oxytocin for Children with Prader-Willi Syndrome Up to Age 4
FranceStudy on Cladribine for Treating Secondary Progressive Multiple Sclerosis in Patients with Recent Progression and No Recent Relapses
PolandStudy on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy
DenmarkStudy on the Effects of GTX-102 for Children with Angelman Syndrome
GermanyStudy on the Safety and Effects of AMT-162 Gene Therapy for Adults with SOD1 ALS
SwedenStudy of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome
PolandStudy on Atogepant for Preventing Menstrual Migraine in Women
CzechiaStudy of AGuIX Nanoparticles and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma
FranceStudy on the Effects of Doxorubicin and Temozolomide After Radiotherapy in Children and Young Adults with Glioblastoma
ItalyStudy on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy
BulgariaStudy of Amlenetug for Patients with Multiple System Atrophy
FranceThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
